EU recognition boosts Bimzelx’s profile as innovative interleukin-17 inhibitor therapy 29-Jun-2023 By Isabel Cameron UCB recently announced the European Commission approval for Bimzelx (bimekizumab), its humanized monoclonal IgG1 antibody.
Preventing cellular hijacking: Study pinpoints potential pathway to new therapeutic approaches for COVID-19 16-Feb-2021 By Jane Byrne Researchers at the European Molecular Biology Laboratory (EMBL) have identified sequences in human proteins that might be used by SARS-CoV-2 to infect cells.